Antibiotic Tablets, Capsule & Syrup

Broad-Spectrum Antibiotics Portfolio (Fluoroquinolones, Cephalosporins, Macrolides)

Bulk Antibiotic APIs & Formulations for Pharmaceutical Manufacturers & Distributors

 

Pharmint offers a comprehensive catalog of broad-spectrum antibiotics, including GMP-certified APIs, oral solid dosage forms, dry syrups, and injectables. Our portfolio supports sourcing professionals, CROs, CMOs, and pharmaceutical buyers seeking high-purity, regulatory-compliant antibacterial agents for global markets.

Covering major pharmacological classes—fluoroquinolones, cephalosporins, macrolides, aminoglycosides, oxazolidinones, and β-lactamase inhibitor combinations—our range is built for scalable procurement, regional export compliance, and pharmaceutical R&D.

What Are the Major Antibiotic Classes Offered in This Collection?

Fluoroquinolones

• Levofloxacin 500 mg Tablet, Moxifloxacin, Ciprofloxacin Tablets USP 250 mg
• Available in tablets, injectables like Levofloxacin 100 mL
• Suitable for UTI, GI infections, and respiratory infections

Cephalosporins

• Cefixime 200 mg DT, Cefpodoxime Proxetil DT 100 mg, Ceftriaxone 1000 mg + Tazobactam 125 mg Injection
• Offered in dry syrups, formulations like Synsef-1500 and Synsef-500
• Covers Gram-positive and Gram-negative pathogens

Macrolides

• Azithromycin 250 mg Tablets (Resimycin), Roxithromycin 150 mg, Clarithromycin Tablets
• Key for RTIs, ENT infections, and pediatric dosing
• Pediatric Erythromycin Ethyl Succinate 125 mg/5 mL also available

Aminoglycosides & Advanced Classes

• Amikacin 2 mL Injection, Linezolid 100 mg Dry Syrup
• Targets serious Gram-negative and resistant infections
• Injectable and oral R&D-ready formats

What Are the Applications and Use Cases for These Antibiotics?

Our antibiotics portfolio supports:

• Contract manufacturing in generic antibiotic markets
• Custom formulation development in hospital injectables
• Clinical research supplies for infectious disease programs
• Export-ready dossiers for regulated and semi-regulated markets

How Should These Antibiotics Be Stored and Handled?

Store in a cool, dry, light-protected environment. Reconstituted injectables and suspensions should follow appropriate cold chain and stability conditions. Specific conditions vary by API.

What Are the Regulatory and Export Requirements for This Collection?

All products are marked for research or pharmaceutical manufacturing only. Not for human use without regulatory approval. Export requires end-use declaration.

Why Should B2B Buyers Source Antibiotics from Pharmint?

• GMP-Certified Facilities: Assured quality and batch reproducibility
• COA/MSDS/DMF Support: Full documentation for regulatory filings
• Research Use & Export Compliance: Clearly labeled per end-use guidelines
• B2B Pricing: Competitive quotes for bulk purchases, MOQs, and lead time clarity
• End-to-End Logistics: International shipping with cold chain options

Bulk Antibiotic Sourcing FAQs

What regulatory documents are required to import antibiotics for pharmaceutical use?

Pharmaceutical buyers must ensure supplier provides GMP certificate, COA, MSDS, and end-use declaration; import permit varies by country and intended formulation use.

Can I request antibiotics in custom strengths or combinations for formulation development?

Yes, Pharmint enables formulation teams to source antibiotics in tailored strengths or FDCs under MOQ terms, supporting contract manufacturing or R&D programs.

How do I verify the antibiotic’s compliance with USP or EP standards?

Antibiotic compliance is confirmed by COA specifications that match USP/EP monographs; Pharmint includes test results, assay, and impurity data in every batch.

Is cold chain shipping required for antibiotic injectables?

Cold chain logistics is required if the injectable antibiotic degrades at ambient temperatures; storage condition is defined by label and stability data on COA.

What are the key factors to consider when selecting a B2B antibiotic supplier?

Key buyer criteria include GMP facility validation, regulatory documentation, batch reproducibility, lead times, and antibiotic scope across pharmacological classes.